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Increasing evidence indicates the importance of extracellular adenosine triphosphate
(ATP) in the modulation of neuronal function. In particular, fine control of ATP release
and the selective and discrete ATP receptor operation are crucial elements of the
crosstalk between neuronal and non-neuronal cells in the peripheral and central nervous
systems. In peripheral neurons, ATP signaling gives an important contribution to neuronal
sensitization, especially that involved in neuropathic pain. Among other subtypes, P2X3
receptors expressed on sensory neurons are sensitive even to nanomolar concentrations
of extracellular ATP, and therefore are important transducers of pain stimuli. P2X3 receptor
function is highly sensitive to soluble factors like neuropeptides and neurotrophins,
and is controlled by transduction mechanisms, protein-protein interactions and discrete
membrane compartmentalization. More recent findings have demonstrated that P2X3
receptors interact with the synaptic scaffold protein calcium/calmodulin-dependent serine
protein kinase (CASK) in a state dependent fashion, indicating that CASK plays a
crucial role in the modulation of P2X3 receptor stability and efficiency. Activation of
P2X3 receptors within CASK/P2X3 complex has important consequences for neuronal
plasticity and possibly for the release of neuromodulators and neurotransmitters. Better
understanding of the interactome machinery of P2X3 receptors and their integration with
other receptors and channels on neuronal surface membranes, is proposed to be essential
to unveil the process of neuronal sensitization and related, abnormal pain signaling.
Keywords: trigeminal neurons, pain, receptor plasticity, purinergic signaling, migraine
INTRODUCTION
ADENOSINE TRIPHOSPHATE AS A CHEMICAL INDUCER OF
SENSITIZATION
Sensitization is a process whereby primary sensory neuron affer-
ents and central synapses become hyper-responsive to extra-
cellular nociceptive stimuli so that they underlie neuropathic
and chronic pain, including allodynia, hyperalgesia and spon-
taneous pain. Peripheral and central sensitization are thought
to be supported by enhanced release of neurotransmitters and
peptides, often co-released with adenosine triphosphate (ATP),
from primary afferents to spinal synapses (Bardoni et al., 1997).
Activation of the corresponding receptors in postsynaptic dorsal
horn neurons induces central sensitization.
Fast conductive myelinated Aδ fibers and slow non-myelinated
C-fibers sense different stimuli, in particularmechanical/chemical
or tactile stimuli (Basbaum et al., 2009). Whether A- or C-
fibers are more important for the generation of spontaneous
firing in neuropathic pain, remains an unanswered question. One
important priority for translational medicine is the identification
of biomarkers for the functional role of distinct classes of C-
fibers and Aδ fibers and for their transition from mono- to
poly-modal function in chronic pain. It is not excluded that
cellular crosstalk at ganglion level might also induce functional
plasticity in non-nociceptive neurons to be recruited in persis-
tent allodynia (Ueda, 2008). The recruitment of non-nociceptive
sensory fibers generates an additional level of complexity that
renders the sensitization incompletely understood in its complex
molecular constituents and temporal evolution, with consequent
slow development of new drugs to prevent/revert it.
One important consideration regards the differential contri-
bution of sensory fibers in humans and rodents and, therefore,
the difficulties to apply experimental data to clinically-useful
models. Experiments performed with infrared diode laser stim-
ulation on human subjects affected by painful neuropathies have
demonstrated that pain conditions are associated with impaired
function of Aδ fibers and low involvement of un-myelinated
C-fibers (Tzabazis et al., 2011; Moeller-Bertram et al., 2013),
while the opposite is found in rodents (Shields et al., 2010;
Zhang et al., 2013). Nonetheless, a species-dependent difference
in neural substrates of pain, as recently found in P2X3 receptor
sequence (Serrano et al., 2012; Sundukova et al., 2012), does
not exclude similar chemo-transduction mechanisms based on
analogous mediators and modulators.
The molecular basis of transitions from acute sensitization to
long-term hypersensitivity relies on complex temporal and spatial
molecular mechanisms that are primed by exposure to soluble
factors and intracellular neuronal and non-neuronal signaling.
Gene expression and protein trafficking then strongly contribute
to change pain receptor expression, supporting dysfunctional
action potential firing into aberrant neurotransmitter release at
the presynaptic terminal and, thus, inducing central sensitization
of spinal and brainstem networks.
Among the soluble and cellular factors responsible for the
early molecular signature of fiber sensitization and spontaneous
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aberrant firing in a variety of pain-related diseases, one pow-
erful candidate molecule is extracellular ATP (Hamilton and
McMahon, 2000), co-released with other neurotransmitters and
peptides or after mechanical stress by a number of different mech-
anisms (Corriden and Insel, 2010; Novak, 2011). Indeed, ATP
acute injection activates C-nociceptors in healthy human skin
without the involvement of mechano-responsive or mechano-
insensitive C-fibers (Hilliges et al., 2002). ATP (whose extracellu-
lar concentration is limited in time and space by ectonucleotidases
that generate active metabolites) binds to different subtypes of
ligand-gated P2X channels or metabotropic P2Y receptors (Burn-
stock, 2008), amplifying the spectrum of reactive molecules in the
extracellular space (Browne and North, 2013).
Combinatorial expression of ATP receptors with different
affinity for ATP in distinct cell types allows modulation of
purinergic signaling in different tissues. Primary sensory neurons
widely express P2X3 receptors (Vulchanova et al., 1998) sensitive
to nanomolar ATP concentrations (Sokolova et al., 2006) and
implicated in the modulation of pain sensitivity as demonstrated
using P2X3 knockout (KO) mice (Cockayne et al., 2000; Souslova
et al., 2000; Zhong et al., 2001; Cockayne et al., 2005). Recent
pharmacological research has been directed to discover new drugs
capable of inhibiting P2X3 receptors because their pharmaco-
logical block could provide a significant contribution to reduce
inflammatory and neuropathic pain (Ford, 2012; North and
Jarvis, 2013). Nevertheless, only a few P2X3-selective antagonists
have been reported to date (Jarvis et al., 2002; Ford, 2012) and
are currently undergoing clinical trials (Fabbretti and Nistri,
2012).
While it is well known that changes in the activity of voltage-
gated ion channels expressed by sensory neurons can contribute
to chronic pain sensitization (McCleskey and Gold, 1999), the
focus of the present review is on ATP-mediated signaling since
it represents an early chemical signal that triggers pain in normal
circumstances and that can predate the establishment of neuronal
sensitization (Hamilton and McMahon, 2000). ATP, working
through different (yet unknown) plasticity processes, eventually
confers novel maladaptive activity to neurons and non-neuronal
cells in the entire tissue. Together with ATP, several soluble factors
and neuropeptides like nerve growth factor (NGF), calcitonin
gene-related peptide (CGRP), cytokines and prostaglandins coop-
erate either to directly activate nociceptors (as well as to induce
secondary long-lasting chain of genomic changes) or to evoke
indirect paracrine responses after non-neuronal cells activation
(Shu and Mendell, 2001; Giniatullin et al., 2008; Jakobsson, 2010;
Kuner, 2010; Cady et al., 2011).
ROLE OF ATP-GATED P2X3 RECEPTORS IN NEUROGENIC
INFLAMMATION AND NEURONAL SENSITIZATION
Inflammatory mediators influence neuronal expression of
nociceptors and ion channels including ATP receptors, therefore
contributing to spontaneous activity of sensory fibers and closing
a vicious circle of pathological hyper-responsiveness (Ellis and
Bennett, 2013).
Neuronal/non-neuronal cell crosstalk is highly modulated by
neuronal ATP and its action not only on P2X3 receptors but
also on low affinity ATP receptors (P2X4 or P2X7) known to
give a strong contribution in inflammatory response (Toulme
et al., 2010; Inoue and Tsuda, 2012). In addition, the reactivity of
resident microglia-like cells (macrophages) in ganglia (Villa et al.,
2010; Franceschini et al., 2013a) opens new vistas on the cellular
mechanisms of regulation of neuronal sensitization at ganglion
level.
The inflammatory components of neuropathic pain include
activation of toll-like receptors (TLR) on neurons and non-
neuronal cells (Christianson et al., 2011; Stokes et al., 2013).
Experimental TLR stimulation with the component of the
bacterial wall lipopolysaccharide (LPS) promotes significant up-
regulation of P2X3 receptor function with faster recovery from
desensitization (Franceschini et al., 2013b). This treatment also
facilitates release of ATP (Franceschini et al., 2012) and tumor
necrosis factor alpha (TNFα; Franceschini et al., 2013a). These
data suggest that, in sensory ganglion culture, the development of
a neuroinflammatory profile facilitates the release of endogenous
mediators (including ATP and cytokines) to reinforce the acti-
vation of inflammatory cells and constitutively potentiates P2X3
receptors to amplify nociceptive signaling. Similar purinergic
signaling likely occurs at central synapse, where block of ATP
could represent a potential therapeutic target to limit microglia-
mediated inflammatory responses associated with chronic pain
sensitization (Ulmann et al., 2008; Jakobsson, 2010). The possi-
bility of ATP-mediated crosstalk also within ganglia has recently
been proposed (Ceruti et al., 2008; Ohara et al., 2009; Belzer
et al., 2010; Ceruti et al., 2011; Huang et al., 2013), supporting
the intrinsic role of satellite glial cells for adaptation mechanisms
during chronic pain (Hanani, 2012; Kung et al., 2013) and their
role as inflammatory cells (van Velzen et al., 2009).
These observations suggest that there is a complex sequence
of cellular responses that exert chemical tissue priming to cre-
ate the basal conditions permissive for sensitization. In analogy
with adaptive immune responses, we expect that interleukin
(IL-1β) priming causes amplification of antigen-presenting cells
in ganglia, in particular satellite glial cells (Ben-Sasson et al.,
2011).
INTRACELLULAR SIGNALING INDUCES SENSITIZATION VIA
P2X3 RECEPTOR UPREGULATION
A major property of P2X3 receptors is the ability to rapidly
adapt their function to changes in the extracellular milieu via
receptor redistribution, trafficking, and phosphorylation. Our
former studies have demonstrated that P2X3 receptors of trigem-
inal sensory neurons are tightly controlled by the fine balance
between kinases and phosphatases, which regulate even the basal
operational activity of these receptors (Giniatullin et al., 2008).
NGF is sufficient to directly sensitize nociceptive endings
causing spontaneous pain (Bennett et al., 1998; Shu and Mendell,
2001; Rukwied et al., 2013), to sensitize P2X3 expressing nocicep-
tors in mice (Ramer et al., 2001; D’Arco et al., 2007, 2009) and
to induce acute sensitization of nociceptors in man (McKelvey
et al., 2013; Silberstein, 2013). Manipulating NGF levels pro-
duces a major impact on ATP-mediated responses by altering
intraneuronal signaling pathways (D’Arco et al., 2007; Giniatullin
et al., 2008). Pharmacological blockade of protein kinase C (PKC)
or Calcium/calmodulin-dependent protein kinase II (CamKII)
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activation prevents NGF-induced sensitization (Bonnington and
McNaughton, 2003), and NGF neutralization unleashes the Sar-
coma tyrosine kinase (Src) kinase blocker C-terminal Src kinase
(Csk) to limit P2X3 receptor function at membrane level (D’Arco
et al., 2009) and to inhibit neuronal sensitization (Liu et al., 2008).
cAMP response element binding protein (CREB)-mediated gene
expression in dorsal horn neurons establishes peripheral and
central sensitization (Fang et al., 2002) suppressed by extracellular
signal-regulated kinase (ERK) blockers, and by protein kinase
A (PKA), PKC or CaMK inhibitors (Kawasaki et al., 2004). In
line with these data, CGRP signaling pathways activate CREB-
mediated P2X3 receptor expression and function (Simonetti et al.,
2008).
Using a transgenic knock-in (KI) mouse exhibiting CaV2.1
R192Q mutated voltage-gated calcium channels (P/Q-type)
(Tottene et al., 2009), we previously identifiedmultiple interactors
(calcineurin, Cyclin-dependent kinase 5 (Cdk5) and CaMKII)
associated to the gain of function of the mutated channel lead-
ing to larger intracellular calcium levels that modulate P2X3
receptor function in trigeminal sensory neurons. In particular,
enhanced P2X3 receptor-mediated responses are found in KI
neurons that depend on constitutive activation of CaMKII and
are reversed by the selective CaV2.1 channel blocker ω-Agatoxin
or by pharmacological block of CaMKII (Nair et al., 2010a).
CaMKII sensitivity to intracellular calcium levels, is an impor-
tant switcher of different intracellular pathways (i.e., Cdk5) that
influence P2X3 receptor activity and function, as demonstrated
in mice expressing CaV2.1 mutated channels (Nair et al., 2010a).
CaMKII is also involved in P2X3 receptors export towards the
surface membrane (Xu and Huang, 2004; Fabbretti et al., 2006;
Hasegawa et al., 2009), a process that is largely dependent on
ambient temperature (Pryazhnikov et al., 2011). Furthermore,
the typical agonist-evoked desensitization of P2X3 receptors is
associated to dynamic, calcium-sensitive redistribution of such
receptors to lipid raft domains (Vacca et al., 2009; Gnanasekaran
et al., 2011) and internalization (Vacca et al., 2011; Chen et al.,
2012). Thus, the intracellular calcium homeostasis is important
to modulate P2X3 receptor responses, as the calcium sensor neu-
ronal Ca2+−sensor proteins (VILIP1) forms a signaling complex
with P2X receptors and regulates P2X3 receptor sensitivity to ATP,
and it even enhances the neuronal excitability of naive dorsal
root ganglion (DRG) neurons (Chaumont et al., 2008; Liu et al.,
2013).
In order to transduce ATP signals to downstream responses,
we hypothesize that P2X3 receptors require discrete sorting to
membrane compartments where, on a short term on-demand
basis, all the molecular elements necessary for the correct signal
transduction are anchored. Among many, calcium/calmodulin-
dependent serine protein kinase (CASK) is a scaffold protein
of emerging importance (Hsueh, 2011), sensitive to intracellular
calcium, CamKII levels (Lu et al., 2003; Hodge et al., 2006;
Malik et al., 2013) and Cdk5 (Samuels et al., 2007), all ele-
ments known to strongly modulate P2X3 receptors (Nair et al.,
2010a,b).
CASK and P2X3 receptors are found within the same
macromolecular complex: our data suggest that CASK acts
like a docking point to stabilize P2X3 receptors expression at
FIGURE 1 | Scheme of dynamic assembly of the CASK/P2X3 receptor
complex at neuronal membrane level. The scaffold protein CASK (blue;
left) and the P2X3 receptor (yellow) are associated in the same
macromolecular complex. Note that adaptor molecules like CamKII and
Cdk5 (triangles) are proposed to regulate the CASK/P2X3 receptor complex
at membrane level and determine the strength of their interaction. Silencing
CASK (middle and right panels) results in uncoupling of the CASK/P2X3
receptor complex followed by internalization of P2X3 receptors and their
proteasomal degradation, suggesting that CASK is the anchor to maintain
P2X3 receptor at membrane level.
membrane level, as the CASK knockdown results in proteasome-
dependent receptor disassembly and reduced P2X3 receptor cur-
rent (Figure 1; Gnanasekaran et al., 2013). Interestingly, CASK
is typically more directed to lipid rafts (Gnanasekeran and
Fabbretti, unpublish data) and more strongly associated with
P2X3 receptors in the voltage-dependent P/Q-type calcium chan-
nel subunit alpha-1A (CACNA 1A) KI mice (Pietrobon, 2010),
characterized by altered calcium channel and CamKII activity
(Figure 2; Gnanasekeran et al., under revison). In the KI model,
CASK/P2X3 complex is uncoupled by ω-Agatoxin or the CaMKII
inhibitor KN-93, reinforcing the role of intracellular calcium in
the modulation of P2X3 receptors in sensory neurons.
One of the peculiar findings associated with the CASK/P2X3
complex is its dynamic nature that largely depends on the receptor
functional activity (Figure 3; Gnanasekaran et al., 2013). In par-
ticular, nociceptive stimulation with NGF application strengthens
P2X3/CASK co-purification, while P2X3 receptor function is
sufficient to dissociate the complex (Gnanasekaran et al., 2013).
It is, therefore, likely that both P2X3 receptor activity and CASK
regulators (as CaMKII) control the CASK/P2X3 complex. In
its role as scaffold protein, CASK links different adaptors and
molecules (including other channels) to elicit further downstream
signaling, like the stability and trafficking of receptors towards
the membrane (Hsueh, 2011) and vesicle release (Spangler et al.,
2013). In brain synapses, CASK has a negative role, as facil-
itated glutamatergic release was observed in KO CASK mice
FIGURE 2 | Scheme of the CASK/P2X3 receptor complex in the R192Q
mutation of the cacna1a gene. Both CASK and P2X3 receptors are more
expressed in membrane lipid rafts of missense Cacna1a KI neurons,
suggesting a role of CASK in creating larger P2X3 receptor clusters. CaV2.1
R192Q channel gain of function and enhanced CamKII activity produced by
the increased influx of calcium are important for the formation of the
CASK/P2X3 complex and receptor function.
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FIGURE 3 | Idealized diagram of the dynamic nature of the CASK/P2X3
complex. P2X3 receptor agonist application (α,β) induces an inward
cationic current (left panel) that requires correct assembly of CASK/P2X3.
When the agonist application is sustained to produce receptor
desensitization, disassembly of the CASK/P2X3 complex occurs (middle).
Thus, untethered CASK can be redirected to distinct downstream signaling
(right panel) via multiple effectors (red dots).
(Atasoy et al., 2007), in agreement with the inhibitory effect
of CASK over the P2X3 over-reactivity (Gnanasekaran et al.,
2013).
Recent findings suggest that CASK, known to modulate export
and trafficking of N-methyl-D-aspartate (NMDA) receptors (Jey-
ifous et al., 2009), induces synapse-associated protein 97 (SAP97)
conformation changes to control the rate of glutamate recep-
tor insertion into the synaptic compartment (Lin et al., 2013).
Whether a similar process occurs in sensory ganglia or at central
synapse, and if ATP has a role in this modulation remain a matter
for future studies.
It is possible that altered CASK targeting in chronic pain states
could impair communication between satellite cells and neu-
rons via aberrant gap junction/hemichannels function (Márquez-
Rosado et al., 2012) and with possible damage of neuro-satellite
cell units. In particular, binding of CASK to neurexins and neu-
roligins in heterologous synapses (Fairless et al., 2008; Gokce and
Südhof, 2013), indicates its potential involvement in a structural
process to shape the extent and location even of neuron/non-
neuronal cell communication.
Furthermore, at central level, it seems likely that presynaptic
CASK/P2X3 functional interaction regulates synaptic strength in
the spinal dorsal horn, reinforcing the interest for P2X3 receptors
as key modulators of the fiber sensitivity in chronic pain.
CONCLUSIONS
In view of their high agonist affinity, P2X3 receptors appear as
major candidates to sense even small changes in extracellular ATP
and transduce them into downstream neuronal responses. Fur-
ther potentiation of the ATP effects is determined by intracellular
calcium signaling and subsequent kinase activation that medi-
ates P2X3 receptor phosphorylation, expression and turn-over.
Finally, membrane specialized domains could convey specific
responses via dedicated signal transduction machinery whereby
CASK could serve as a platform to orchestrate ATP signaling
through sorting and redistribution of P2X3 receptors. ATP recep-
tor stimulation could determine further release of neuromodula-
tors (Gu and MacDermott, 1997), recruitment of inflammatory
cells and progression to neuronal sensitization, thus contributing
to fine regulatory mechanisms and strong plasticity of sensory
neurons. Understanding the spatio-temporal scale of these pro-
cesses is a priority to propose molecular targets useful for clinical
applications to chronic pain.
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